A collaborative study with Harvard Medical School
Bioactive Microfibre Gelling (BMG™) Technology in the Management of Lower Limb Ulcers: A Portuguese Perspective
Publication Details:
Santos, V. & Santos, A.S. (n.d.) Bioactive Microfibre Gelling (BMG™) technology in the management of lower limb ulcers: A Portuguese perspective.
Wound Details
5 patients, aged 43-87 years, with wounds lasting 2-8 months
Types of Wounds:
Venous ulcers
Arterial ulcers
Mixed lower limb ulcers
Key Findings and Data:
- 4 out of 5 patients showed a clear transition from chronic, non-healing wounds to granulation and eventual healing.
- Increased healthy granulation tissue observed in all cases.
- MaxioCel dressing controlled high exudate levels, supporting faster healing.
- Granulation improved from 85% to 100% within 4 weeks.
- Necrosis reduced from 25% to 0% over 3 weeks.
- Wound fully healed (100% epithelialization) by Week 3.
- Pain score reduced from 5 to 0 (VAS Scale).
Key Insights
- MaxioCel effectively addressed wound complexity, reducing chronicity and enhancing healing progression.
- MaxioCel dressing maintained a cohesive structure, promoting antimicrobial and anti-biofilm effects.
Related Publications
Evaluation of a 100% Chitosan Dressing in the Treatment of Diabetic Foot Ulcers
Chronic Wound Debridement in an Acute Setting
Severe Pressure Ulcer Debridement in the Acute Sector
A Multi-disciplinary Team Approach to the Management
